General Oncology

Differences in Treatment Site of Care: Why Is My Insurer Sending Me to a Particular Treatment Center?

Differences in Treatment Site of Care: Why Is My Insurer Sending Me to a Particular Treatment Center?

By

This fact sheet discusses the differences in cost between cancer care at physician offices and health system-based sites of care.

Cancer Recurrence Statistics

Cancer Recurrence Statistics

By

This fact sheet describes the estimated rates of recurrence of selected cancers.

Understanding Drug Approval and Researching Newly Approved Cancer Treatments

Understanding Drug Approval and Researching Newly Approved Cancer Treatments

By

This fact sheet provides patient-focused information about the FDA drug approval process and guidance on researching FDA-approved agents for patients with cancer.

Gender-Based Differences in Chemotherapy: Efficacy and Safety

Gender-Based Differences in Chemotherapy: Efficacy and Safety

By

Women and men were found to react differently to treatment with chemotherapy, although gender-based survival differences were not observed.

Study Shows Prevalence of Lynch Syndrome in Solid Tumors Through MSI Status

Study Shows Prevalence of Lynch Syndrome in Solid Tumors Through MSI Status

By

The findings suggest that changes in genetic testing criteria are warranted.

Appropriate Integration of Radiotherapy in Cancer Care: A Call to Action From Researchers

Appropriate Integration of Radiotherapy in Cancer Care: A Call to Action From Researchers

By

A report highlights the current gap in the utilization of radiotherapy in Europe and outlines an action plan as a solution.

Palliative Care and Survivorship

Palliative Care and Survivorship

By

This fact sheet discusses the importance of palliative care as it pertains to cancer survivorship.

Moving Targets: Off-Label Prescribing of Targeted Therapies

Moving Targets: Off-Label Prescribing of Targeted Therapies

By

By way of the TAPUR study, researchers are attempting to evaluate the activity of targeted therapies when they are used in an off-label setting.

Nutraceuticals/Supplements and Cancer Prevention: All Hype?

Nutraceuticals/Supplements and Cancer Prevention: All Hype?

By

This fact sheet discusses the research on supplement use and cancer incidence.

The Patient Behind the EHR: Oncologists Only See Half the Picture

The Patient Behind the EHR: Oncologists Only See Half the Picture

By

Dr Vorobiof discusses the importance patient factors that can be missed via standard data collection methods for patients with cancer.

Study Identifies Factors for Reducing Febrile Neutropenia

Study Identifies Factors for Reducing Febrile Neutropenia

By

Disruptions in barrier integrity, use of corticosteroids, and use of intravenous antibiotics prior to chemotherapy may increase risk of febrile neutropenia.

Progression-Free Survival and Patient Quality of Life Are Not One and the Same

Progression-Free Survival and Patient Quality of Life Are Not One and the Same

By

To make informed treatment decisions, the affect a drug has on a patient's quality of life must be considered, investigators argued.

cfDNA Holds Great Potential to Transform Cancer Medicine

cfDNA Holds Great Potential to Transform Cancer Medicine

By

Integration of liquid biopsies will require understanding of their advantages and limitations.

Thoracic US Score Predicts Pleurodesis Success in Malignant Pleural Effusion

Thoracic US Score Predicts Pleurodesis Success in Malignant Pleural Effusion

By

A pleural adherence score derived from thoracic ultrasound at 24 hours post-talc administration is predictive of long-term pleurodesis success in patients with symptomatic malignant pleural effusion.

Guideline Updates on Quality Palliative Care

Guideline Updates on Quality Palliative Care

By

A draft guideline from the National Consensus Project for Quality Palliative Care describes best practices for caring for individuals who are seriously ill.

5 Key Findings Presented at the 2018 World Cancer Congress

5 Key Findings Presented at the 2018 World Cancer Congress

By

Health experts from around the world shared research at the 2018 World Cancer Congress. We recapped 5 key findings presented at the event.

Familial Exposure to Radiation During Treatment for Cancer

Familial Exposure to Radiation During Treatment for Cancer

By

This fact sheet discusses the risk of familial exposure to radiation during cancer treatment and strategies to help limit incidental contact with potentially harmful byproducts.

Commission Calls for Integration of Oncology and Palliative Care

Commission Calls for Integration of Oncology and Palliative Care

By

A recent Lancet Oncology Commission laid out why oncology and palliative care should be integrated and how to achieve successful integration despite barriers.

Organic Food Consumption Linked to Lower Cancer Risk, But Further Study Needed

Organic Food Consumption Linked to Lower Cancer Risk, But Further Study Needed

By

Is a higher frequency of organic food consumption correlated to a lower risk of cancer?

Who Determines What 'Value' Looks Like in Value-Based Cancer Care?

Who Determines What 'Value' Looks Like in Value-Based Cancer Care?

By

Evaluation of patient-reported outcomes (PROs) is an important component of measuring quality in cancer care.

Expert Panel Provides Recommendations for Running Trials on Intratumoral Immunotherapy

Expert Panel Provides Recommendations for Running Trials on Intratumoral Immunotherapy

By

Guidelines could help standardize the approaches used to conduct human intratumoral immunotherapy research.

Reclassification of Variants of Uncertain Significance: A Q&A With Theodora Ross MD, PhD

Reclassification of Variants of Uncertain Significance: A Q&A With Theodora Ross MD, PhD

By

Dr Ross described how genomic reports may need to be updated to account for new insights into a variant's role in cancer.

Prisoner or Patient? Challenges of Cancer Care in the Incarcerated Population

Prisoner or Patient? Challenges of Cancer Care in the Incarcerated Population

This in-depth review examines the inherent challenges of providing cancer care for incarcerated patients.

Assays May Help Researchers Discover Factors Underlying Immunotherapy Response

Assays May Help Researchers Discover Factors Underlying Immunotherapy Response

By

A suite of assays that rely on a single instrument and its related software could help researchers identify factors that drive immunotherapy response.

Larotrectinib Continues to Show Efficacy in <i>TRK</i>-Fusion Cancers

Larotrectinib Continues to Show Efficacy in TRK-Fusion Cancers

By

The TRK inhibitor larotrectinib continues to show efficacy in TRK-fusion cancers, regardless of patient age or cancer type.

Entrectinib Shrank <i>NTRK</i> Fusion-Positive Solid Tumors

Entrectinib Shrank NTRK Fusion-Positive Solid Tumors

By

More than half of patients with central nervous system metastases responded to the drug.

Plastics and Cancer

Plastics and Cancer

By

Few studies have evaluated the general exposure to plastics and cancer risk, and data on cancer risk among workers in the plastic industry are inconclusive.

The Price Is Right for CAR-T in Pediatric Patients, Analysis Concludes

The Price Is Right for CAR-T in Pediatric Patients, Analysis Concludes

By

For children with relapsed or refractory B-cell acute lymphoblastic leukemia, tisagenlecleucel was deemed cost-effective, yet long-term outcomes are still uncertain.

Using ctDNA to Predict Cancer Recurrence and Guide Therapy Selection

Using ctDNA to Predict Cancer Recurrence and Guide Therapy Selection

By

A ctDNA testing method has the capability to predict cancer recurrence, which could help guide therapy selections and uncover new drug development opportunities.

A Vegan Diet and Cancer

A Vegan Diet and Cancer

By

There are no data on whether a vegan diet is an effective means of cancer prevention among high-risk populations.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs